Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-01

FDA Approved: BUPROPION HYDROCHLORIDE SR — Original Application (Dr. Reddys Laboratories Inc.)

View source ↗

Summary

FDA approved Dr. Reddy's Laboratories' generic version of bupropion hydrochloride sustained-release (SR) under an Original Application (ANDA205794).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride sustained-release (Bupropion hydrochloride)

Snippet

ORIG AP for BUPROPION HYDROCHLORIDE SR (BUPROPION HYDROCHLORIDE)